Effective treatment option (not only) for advanced renal cell carcinoma

被引:0
|
作者
不详
机构
关键词
TUMOR-CELLS; CABOZANTINIB; INHIBITOR;
D O I
10.1159/000537951
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:112 / 113
页数:2
相关论文
共 50 条
  • [21] Sunitinib in the treatment of advanced renal cell carcinoma
    Drab-Mazur, Iwona
    ONCOLOGY IN CLINICAL PRACTICE, 2014, 10 : A43 - A44
  • [22] Axitinib for the treatment of advanced renal cell carcinoma
    Akaza, Hideyuki
    Fukuyama, Tomofusa
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (02) : 283 - 297
  • [23] Sunitinib treatment for advanced renal cell carcinoma
    Stanislawiak-Rudowicz, Joanna
    ONCOLOGY IN CLINICAL PRACTICE, 2014, 10 : A17 - A18
  • [24] Nivolumab in the treatment of advanced renal cell carcinoma
    Arasaratnam, Malmaruha
    Gurney, Howard
    FUTURE ONCOLOGY, 2018, 14 (17) : 1679 - 1689
  • [25] Everolimus for the treatment of advanced renal cell carcinoma
    Amato, Robert
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (07) : 1143 - 1155
  • [26] Temsirolimus in the treatment of advanced renal cell carcinoma
    Gore, M. E.
    ANNALS OF ONCOLOGY, 2007, 18 : 87 - 88
  • [27] DISPARITIES IN THE TREATMENT OF ADVANCED RENAL CELL CARCINOMA
    Metcalf, Meredith
    Pena, Vanessa
    Cheaib, Joseph
    Gupta, Gopal
    Pierorazio, Phillip
    Patel, Hiten
    JOURNAL OF UROLOGY, 2021, 206 : E252 - E252
  • [28] CYBERKNIFE RADIOSURGERY AS A SAFE AND EFFECTIVE TREATMENT OPTION FOR VISCERAL AND LYMPH NODE METASTASES OF RENAL CELL CARCINOMA
    Rodler, Severin
    Schott, Melanie
    Tamalunas, Alexander
    Marcon, Julian
    Graser, Annabel
    Casuscelli, Jozefina
    Stief, Christian
    Fuerweger, Christoph
    Muacevic, Alexander
    Staehler, Michael
    JOURNAL OF UROLOGY, 2020, 203 : E173 - E173
  • [29] Nivolumab in the treatment of advanced renal cell carcinoma
    Tomczak, Piotr
    Synowiec, Zuzanna
    ONCOLOGY IN CLINICAL PRACTICE, 2019, 15 (02): : 124 - 126
  • [30] Advanced Nanomaterials for the Diagnosis and Treatment of Renal Cell Carcinoma
    Ji, Chen
    Li, Junru
    Mei, Junyang
    Su, Weiran
    Dai, Huili
    Li, Fengqin
    Liu, Peifeng
    ADVANCED NANOBIOMED RESEARCH, 2023, 3 (02):